Not applicableWithdrawnNCT02112630What this trial is testingBoceprevir in End Stage Renal Disease (ESRD)Who this might be right forHepatitis C InfectionEnd Stage Renal Disease Columbia University
Large-scale testing (Phase 3)Study completedNCT02114151What this trial is testingEfficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and CirrhosisWho this might be right forHepatitis C Virus Infection Janssen Infectious Diseases BVBA 103
Large-scale testing (Phase 3)Study completedNCT03067129What this trial is testingEvaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionWho this might be right forHepatitis C Virus (HCV) AbbVie 129
Testing effectiveness (Phase 2)Study completedNCT01858766What this trial is testingSafety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 379
Not applicableStudy completedNCT00863109What this trial is testingQuality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)Who this might be right forHepatitis C, ChronicGenotype 1HCV-1 Merck Sharp & Dohme LLC 133
Large-scale testing (Phase 3)Study completedNCT01896193What this trial is testingSafety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 127
Testing effectiveness (Phase 2)Study completedNCT03036839What this trial is testingLedipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseWho this might be right forHepatitis C Virus Infection Gilead Sciences 95
Post-approval studies (Phase 4)Study completedNCT02761629What this trial is testingEfficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency VirusWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 180
Large-scale testing (Phase 3)Study completedNCT02073656What this trial is testingEfficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infectionWho this might be right forHepatitis C VirusHIV Gilead Sciences 335
Not applicableStudy completedNCT01514890What this trial is testingFrench Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and RibavirinWho this might be right forChronic Hepatitis C ANRS, Emerging Infectious Diseases 675
Testing effectiveness (Phase 2)Study completedNCT01371604What this trial is testingSafety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Ended earlyNCT01080222What this trial is testingA Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectionWho this might be right forChronic Hepatitis C Virus Infection Vertex Pharmaceuticals Incorporated 152
Testing effectiveness (Phase 2)Study completedNCT00735969What this trial is testingHigh-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1Who this might be right forChronic Hepatitis C National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 21
Not applicableStudy completedNCT04577482What this trial is testingStudy of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological ResponseWho this might be right forHepatitis C Virus (HCV) AbbVie 42
Large-scale testing (Phase 3)Study completedNCT03833362What this trial is testingEfficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)Who this might be right forHepatitis C R-Pharm 420
Large-scale testing (Phase 3)Study completedNCT01241760What this trial is testingVX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus InfectionWho this might be right forGenotype 1 Chronic Hepatitis CTreatment Naive Janssen Infectious Diseases BVBA 744
Large-scale testing (Phase 3)Study completedNCT01768286What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV InfectionWho this might be right forChronic Hepatitis C Virus Gilead Sciences 441
Large-scale testing (Phase 3)Study completedNCT03089944What this trial is testingGlecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated CirrhosisWho this might be right forHepatitis C Virus (HCV) AbbVie 343
Large-scale testing (Phase 3)Ended earlyNCT02504099What this trial is testingEvaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaWho this might be right forChronic Hepatitis C Infection AbbVie 3
Early research (Phase 1)Study completedNCT01590407What this trial is testingFirst in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C, Chronic Alios Biopharma Inc. 71